Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens

Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in Canada.

PanOptix Pro uses proprietary ENLIGHTEN NXT Optical technology to deliver the lowest light scatter and highest light utilization reported for any trifocal intraocular lens. The lens has achieved a record 94% light utilization, which is significant against the theoretical maximum of 96% for diffractive optics.

Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens

A doctor wearing scrubs using a centurion vision system to check a patient’s eye.

Moreover, the technology used in making these lenses also improves light distribution, while increasing the optical image contrast between distance and intermediate vision by 16%. The PanOptix Pro is expected to be available in Canada from Alcon Inc. (NYSE:ALC) in the single-use Clareon AutonoMe preloaded delivery system by early 2026.

Alcon Inc. (NYSE:ALC) is a leading eye care company that specializes in developing a range of eye care products. The company operates through two main business segments, including the Surgical Business and Vision Care Business.

While we acknowledge the potential of ALC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.